In glioma CSCs, the close collaboration between BTK and mTOR/VEGF axis can reduce stemness potential and angiogenesis capacity via the regulation of CD31+ cells, indicating the critical role of BTK/mTOR/VEGF in the progression of tumour mass via vasculogenesis (Figure 4).94 The gene discussed is BTK; the disease is central nervous system cancer.